Get started
Yuka Group Inc.Yuka Group Inc.Yuka Group Inc.

Yuka Group Inc.

No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals

Fundamentals and stats

OverviewStatementsStatisticsDividendsEarningsRevenue

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Yuka Group, Inc. is a holding company, which operates through its fully owned subsidiary. Its products include Testosterone Replacement Therapy, Platelet Rich Plasma Injections, PT-141 Peptide Therapy, Trimix and Quadmix Injections, and Pulse Focused Waive Therapy. The company was founded on May 30, 1991 and is headquartered in Aventura, FL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
YUKA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company